| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130023654 Antibodies to matrix metalloproteinase 9 |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023587 Compositions and methods for the treatment of cancer |
| 01/24/2013 | US20130023580 Compositions and Methods for Inhibiting Expression of XBP-1 Gene |
| 01/24/2013 | US20130023578 siRNA for inhibition of c-Met expression and anticancer composition containing the same |
| 01/24/2013 | US20130023577 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023522 Benzamides |
| 01/24/2013 | US20130023499 Certain substituted amides, method of making, and method of use thereof |
| 01/24/2013 | US20130023498 MicroRNA Modulators and Method for Identifying and Using the Same |
| 01/24/2013 | US20130023488 Methods and compounds for reducing intracellular lipid storage |
| 01/24/2013 | US20130023481 Adenovirus E1A Fragments for Use in Anti-Cancer Therapies |
| 01/24/2013 | US20130023477 Growth hormone fusion proteins |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023461 Oligopeptide compounds and uses thereof |
| 01/24/2013 | US20130023460 Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| 01/24/2013 | US20130023416 Methods and compositions to produce rice resistant to accase inhibitors |
| 01/24/2013 | US20130023051 Techniques for transfecting protoplasts |
| 01/24/2013 | US20130023050 Method for culture of corneal endothelial cells, process for production of corneal endothelial cell sheet for transplantation purposes, and culture kit for corneal endothelial cells |
| 01/24/2013 | US20130023049 Viable cells from frozen umbilical cord tissue |
| 01/24/2013 | US20130023048 Method of Inducing High Activity of Human Adipose Stem Cell and Medium Therefor |
| 01/24/2013 | US20130023047 Nucleic Acids Encoding Humanized Anti-CD40 Antibodies |
| 01/24/2013 | US20130023046 Multipotent adult stem cell population |
| 01/24/2013 | US20130023045 Induced hepatic stem cell and process for production thereof, and applications of the cell |
| 01/24/2013 | US20130023041 Method and Apparatus for Holding Cells |
| 01/24/2013 | US20130023034 Mutated rep encoding sequences for use in aav production |
| 01/24/2013 | US20130023033 Pharmacologically induced transgene ablation system |
| 01/24/2013 | US20130023031 Pseudoinfectious Flavivirus and Uses Thereof |
| 01/24/2013 | US20130023029 Novel asparaginases and uses thereof |
| 01/24/2013 | US20130023028 Variants Of A Polypeptide With Lipolytic Activity and Improved Stability |
| 01/24/2013 | US20130023025 Method for separating cells, cell culture substrate, and device for separating cells |
| 01/24/2013 | US20130023024 Conjugate of magnetic particle and surface modifier linked through cleavable peptide bond |
| 01/24/2013 | US20130023023 Anti-cancer agent |
| 01/24/2013 | US20130023012 Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same |
| 01/24/2013 | US20130023008 Histological method |
| 01/24/2013 | US20130023003 Kit including substrates with various surface chemistries |
| 01/24/2013 | US20130022989 Dental stem cell reprogramming |
| 01/24/2013 | US20130022986 Method for manufacturing pancreatic-hormone-producing cells |
| 01/24/2013 | US20130022964 Use of Ribozymes in the Detection of Adventitious Agents |
| 01/24/2013 | US20130022724 Lettuce sister lines px06514083, px06514153, px06514201 and px06514204 |
| 01/24/2013 | US20130022707 Grain quality through altered expression of seed proteins |
| 01/24/2013 | US20130022680 Modalities for the treatment of degenerative diseases of the retina |
| 01/24/2013 | US20130022666 Methods and compositions for transfer of mitochondria into mammalian cells |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022623 Antibodies that specifically bind to tim3 |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022618 Human cytomegalovirus neutralizing antibodies and use thereof |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022611 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 01/24/2013 | US20130022607 Mucosal vascular addressins and uses thereof |
| 01/24/2013 | US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/24/2013 | US20130022604 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/24/2013 | US20130022603 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/24/2013 | US20130022602 Methods and compositions to modulate antiviral and immune activity responses |
| 01/24/2013 | US20130022597 Antibodies Directed To GPNMB And Uses Thereof |
| 01/24/2013 | US20130022595 Variants of humanized immunomodulatory monoclonal antibodies |
| 01/24/2013 | US20130022590 Compositions Comprising Zinc Finger Domains and Uses Therefor |
| 01/24/2013 | US20130022585 Regeneration and repair of neural tissue using postpartum-derived cells |
| 01/24/2013 | US20130022584 Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof |
| 01/24/2013 | US20130022583 Direct Conversion of Cells to Cells of Other Lineages |
| 01/24/2013 | US20130022582 Multipotent nestin-positive cells |
| 01/24/2013 | US20130022581 Placental stem cell populations |
| 01/24/2013 | US20130022580 Preparation and use of meristematic cells belonging to the dendrobium phalaenopsis, anisellia, polyrrhiza, vanilla, cattleya and vanda genera with high content of phenylpropanoids, hydrosoluble polysaccharides and extensins |
| 01/24/2013 | US20130022541 FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death |
| 01/24/2013 | US20130022539 Ovr115 antibody compositions and methods of use |
| 01/24/2013 | DE112011100940T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
| 01/24/2013 | DE102005018644B4 Implantat zur Behandlung von Röhrenknochendefekten, Verwendung eines Flächengebildes in einem solchen Implantat, sowie Verfahren zur Herstellung des Implantats Implant for the treatment of long bone defects, use of a sheet in such an implant and methods for the preparation of the implant |
| 01/24/2013 | CA2842023A1 Cell culture apparatus, apparatus for long-term observation of cell culture, method for long-term cell culture, and method for long-term observation of cell culture |
| 01/24/2013 | CA2841994A1 Compositions and methods for immunomodulation |
| 01/24/2013 | CA2841745A1 Rspo binding agents and uses thereof |
| 01/24/2013 | CA2841710A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | CA2841363A1 Photobioreactor |
| 01/23/2013 | EP2548952A2 Mutant enzymes |
| 01/23/2013 | EP2548951A1 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| 01/23/2013 | EP2548950A2 Reprogramming T cells and hematopoietic cells |
| 01/23/2013 | EP2548588A2 Three-dimensional artificial scaffold and method for manufacturing same |
| 01/23/2013 | EP2548576A1 Diagnosis of cancer using anti-desmoglein-3 antibodies |
| 01/23/2013 | EP2547773A1 Plants having enhanced yield-related traits and method for making the same |
| 01/23/2013 | EP2547764A1 Method for inducing differentiation of pluripotent stem cells into mesodermal cells |
| 01/23/2013 | EP2547763A2 Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions |
| 01/23/2013 | EP2547762A2 Light-sensitive ion-passing molecules |
| 01/23/2013 | EP2547761A1 Method of culturing pancreatic islet-like tissues by a tissue complex of pancreas-derived non-endocrinal epithelial cells and vascular endothelial cells |
| 01/23/2013 | EP2547760A1 Preservation solutions for biologics and methods related thereto |
| 01/23/2013 | EP2547288A2 Multilayered vascular tubes |
| 01/23/2013 | CN102892891A Plants having enhanced yield-related traits and method for making the same |
| 01/23/2013 | CN102892890A Plants having enhanced yield-related traits and method for making the same |
| 01/23/2013 | CN102892886A Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
| 01/23/2013 | CN102892883A Gene encoding lignan methyltransferase, and use thereof |
| 01/23/2013 | CN102892880A Bioengineered tissue constructs and methods for producing and using thereof |
| 01/23/2013 | CN102892879A Method and composition for inducing human pluripotent stem cells |
| 01/23/2013 | CN102892878A Cell culture medium comprising small peptides |
| 01/23/2013 | CN102888425A Method for producing astaxanthin by using transgenic plant |
| 01/23/2013 | CN102888417A Endoglucanase gene Ce15A of coding glycosyl hydrolase family 5 and application thereof |
| 01/23/2013 | CN102888416A Beta-glycosidase gene for coding glycosyl hydrolase family and application thereof |
| 01/23/2013 | CN102888413A Hcv基因 Hcv gene |
| 01/23/2013 | CN102888411A Eucalyptus PGEF13 gene and plant expression vector, host cell and applications thereof |
| 01/23/2013 | CN102888410A Eucalyptus PGEF17 gene, and plant expression vector, host cell and application thereof |
| 01/23/2013 | CN102888409A Eucalyptus PGEF 10 gene and plant expression vector, host cell and application thereof |
| 01/23/2013 | CN102888407A Milk goat PLZF gene and application thereof to promoting self-renewal of androgenous stem cells |